LSX2026: Non-opioid pain relief and pharma positivity, with Mike Cooke

R&D
Interview at LSX2026 Mike Cooke

In our penultimate video from this year’s LSX World Congress, web editor Nicole Raleigh spoke with Mike Cooke, CEO of AmacaThera, a leading developer of next-generation hydrogel-based drug delivery solutions that enable precise, tunable, and sustained release to improve a wide range of active therapeutics.

Cooke discusses AmacaThera's clinically validated hydrogel drug delivery platform, non-opioid pain relief, and the current investment landscape, with keen pharma interest a positive boost for an optimistic outlook.

Watch this and other conversations from LSX 2026, as well as BIO-Europe Spring, here.


Market Access
12 questions with: Daniel Kohlstaedt

12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.